(Q38238027)

31 August 2017

title

ACE2/Ang-(1-7) signaling and vascular remodeling (English)

1 reference

31 August 2017

ZhenZhou Zhang

1

1 reference

31 August 2017

LaiJiang Chen

2

1 reference

31 August 2017

JiuChang Zhong

3

1 reference

31 August 2017

PingJin Gao

4

1 reference

31 August 2017

Gavin Y Oudit

5

1 reference

31 August 2017

publication date

8 August 2014

1 reference

Science in China. Series C: Life Sciences

31 August 2017

published in

1 reference

31 August 2017

volume

57

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

802-808

1 reference

ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Apelin is a positive regulator of ACE2 in failing hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Vascular remodeling in hypertension: mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Tubular changes in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Cell signaling of angiotensin II on vascular tone: novel mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 activation improves endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Role of the renin-angiotensin system in vascular diseases: expanding the field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Involvement of NADPH oxidase in age-associated cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4693-3

10.1007/S11427-014-4693-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1017912249

0 references

1 reference